Companies and Foundations

Some companies have a business. Others have a mission. The best have both.

FERO Cancer offers companies the opportunity to align with Spain’s most rigorous translational oncology research mission. With real impact, full transparency, and visibility in the country’s leading scientific excellence environments.

More than 300 companies and brands already collaborate with FERO Cancer. Each from its own position: some by funding research projects, others by associating their brand with the charity Galas, others by creating scientific volunteering programmes for their employees. All with the same goal: to accelerate the science that can beat cancer.

Corporate sponsorship

Corporate sponsorship. Your company at the forefront of oncology research.

FERO Cancer’s corporate sponsorship offers companies access to Spain’s leading oncology research centres, visibility in the country’s top scientific excellence environments, and a direct relationship with the researchers leading translational cancer science.

No sporting or cultural event offers what FERO Cancer can offer a company: access to Spain’s leading oncologists and researchers. Laboratory visits, in-house talks for executive teams, naming rights for projects or research teams. For the right company, this is worth more than any presence in conventional media.

Women greeting each other and smiling at a FERO charity gala

Sponsorship options

Funding for Molecular Diagnostics Units

Associate your brand with one of FERO Cancer’s highest-impact scientific and social projects.

Sponsorship of the FERO Dr. Baselga Fellowship

Support the research talent of the future with FERO Cancer’s most highly funded and prestigious fellowship.

Sponsorship of the FERO Galas

Brand presence at the highest-profile charity events in Barcelona, Madrid, and Valencia.

Strategic partnership

Long-term collaboration with scientific involvement, institutional visibility, and access to FERO Cancer’s network of researchers and centres.

LET’S TALK ABOUT YOUR COMPANY

CSR and philanthropy

CSR and philanthropy. Partnering with FERO Cancer as a reputational asset.

Partnering with FERO Cancer provides companies with a CSR asset with proven scientific impact, full transparency, and the ability to communicate to employees, customers, and investors.

Spain’s Philanthropy Law allows companies to deduct up to 40% of donations to non-profit organisations such as FERO Cancer. A €100,000 contribution sustained over 3 years has a net cost of approximately €50,000, depending on the company’s tax structure.

Beyond the tax benefit, partnering with FERO Cancer offers a CSR case with solid scientific substance. FERO Cancer’s impact reports enable companies to communicate the concrete outcome of their investment in verifiable terms: projects funded, researchers supported, patients benefited.

In an environment where ESG criteria are increasingly relevant for investors, talent, and customers, supporting translational oncology research provides a reputational differentiator that goes beyond conventional sponsorship.

Young researchers analysing a test-tube sample, young talent supported by FERO Cancer fellowships

Corporate volunteering

Corporate volunteering. Your team, committed to science.

FERO Cancer’s corporate volunteering offers teams at partner companies a direct experience of translational oncology research. A way to connect the company’s purpose with FERO Cancer’s mission.

Company team visiting a research laboratory during corporate volunteering with FERO Cancer

Visits to the laboratories of the FERO Molecular Diagnostics Units, talks by researchers for corporate teams, company charity challenges—these activities enable employees to experience first-hand the impact of the research funded by FERO Cancer.

Corporate volunteering with FERO Cancer is also an employer branding tool. Companies that offer their employees the opportunity to actively contribute to a cause with proven scientific impact have a competitive advantage in attracting and retaining talent.